Your browser doesn't support javascript.
loading
Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
Fuster, D; Muñoz, M; Pavia, J; Palacín, A; Bellet, N; Mateos, J J; Martín, F; Ortega, M; Setoain, F J; Pons, F.
Affiliation
  • Fuster D; Nuclear Medicine Department, Hospital Clínic de Barcelona, Barcelona, Spain. dfuster@clinic.ub.es
Nucl Med Commun ; 23(1): 31-8, 2002 Jan.
Article in En | MEDLINE | ID: mdl-11748435
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Adenocarcinoma / Technetium Tc 99m Sestamibi / Carcinoma, Ductal, Breast / Radiopharmaceuticals / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nucl Med Commun Year: 2002 Type: Article Affiliation country: Spain
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Adenocarcinoma / Technetium Tc 99m Sestamibi / Carcinoma, Ductal, Breast / Radiopharmaceuticals / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nucl Med Commun Year: 2002 Type: Article Affiliation country: Spain